Statistics

Total Visits

Views
Denosumab and bone metastasis-free survival in men with castrate-resistant prostate cancer - Subgroup analyses from an international, double-blind, randomized, phase 3 trial79

Select a period of time:

Number of views in the range

Views
Denosumab and bone metastasis-free survival in men with castrate-resistant prostate cancer - Subgroup analyses from an international, double-blind, randomized, phase 3 trial13

Views

Views
October 20250
November 20251
December 20250
January 202610
February 20260
March 20261
April 20261
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States11
Austria1
Colombia1
 

Top cities views

Views
San Jose10
Bogotá1
Innsbruck1
Phoenix1